These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27431884)

  • 21. Acneiform eruption as a probable paradoxical reaction to adalimumab.
    Fernández-Crehuet P; Ruiz-Villaverde R
    Int J Dermatol; 2015 Aug; 54(8):e306-8. PubMed ID: 24697221
    [No Abstract]   [Full Text] [Related]  

  • 22. Psoriasiform dermatitis in a non-psoriatic patient treated with adalimumab.
    Tammaro A; Persechino S; Abruzzese C; Narcisi A; Cortesi G; Parisella FR; Laganà B
    Int J Immunopathol Pharmacol; 2012; 25(2):499-501. PubMed ID: 22697082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence of pustular psoriasis after treatment of Crohn disease with infliximab.
    Pourciau C; Shwayder T
    Pediatr Dermatol; 2010; 27(5):539-40. PubMed ID: 20796241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New-onset psoriasis associated with adalimumab: a report of two cases.
    Glenn CJ; Kobraei KB; Russo JJ
    Dermatol Online J; 2011 Sep; 17(9):15. PubMed ID: 21971280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solitary facial cutaneous chronic inflammatory lesions induced by anti-tumour necrosis factor-α antagonist.
    Haro-Gabaldón V; Ruiz Molina I; Haro-González-Vico V; Solís García E
    Clin Exp Dermatol; 2019 Jan; 44(1):80-82. PubMed ID: 30255515
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical management of paradoxical psoriasiform reactions during TNF- α therapy.
    Navarro R; Daudén E
    Actas Dermosifiliogr; 2014 Oct; 105(8):752-61. PubMed ID: 23938073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psoriasiform Skin Lesions Are Caused by Both Infliximab and Adalimumab in a Patient with Crohn's Disease.
    Cankurtaran E; Ekiz F; Hamamci M; Akinci H; Coskun Y; Yuksel I
    Dig Dis Sci; 2016 Apr; 61(4):1206-7. PubMed ID: 26894400
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis: a report of 2 cases.
    Chu DH; Van Voorhees AS; Rosenbach M
    Arch Dermatol; 2011 Oct; 147(10):1228-30. PubMed ID: 22006150
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diffused suberitrodermic psoriasis induced by infliximab].
    Bruzzese V
    Reumatismo; 2007; 59(4):328-31. PubMed ID: 18157290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skin injuries associated with biological therapy in inflammatory bowel disease: beyond psoriasis.
    Mínguez Sabater A; Martínez Delgado S; Ladrón Abia P; Bastida G
    Gastroenterol Hepatol; 2022 Jan; 45(1):62-63. PubMed ID: 33189407
    [No Abstract]   [Full Text] [Related]  

  • 31. Pustular psoriasis induced by terbinafine : differential diagnosis from acute generalized exanthematous pustulosis.
    Tokuyama Y; Senoh A; Setsu N; Iwatsuki K
    Eur J Dermatol; 2008; 18(6):725-6. PubMed ID: 19049946
    [No Abstract]   [Full Text] [Related]  

  • 32. Safety of Adalimumab and Predictors of Adverse Events in 1693 Japanese Patients with Crohn's Disease.
    Ogata H; Watanabe M; Matsui T; Hase H; Okayasu M; Tsuchiya T; Shinmura Y; Hibi T
    J Crohns Colitis; 2016 Sep; 10(9):1033-41. PubMed ID: 26961546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple paradoxical adverse events in a patient with ankylosing spondylitis treated with adalimumab.
    Toussirot É; Charollais R; Aubin F
    Eur J Dermatol; 2016 Aug; 26(4):406-8. PubMed ID: 27099170
    [No Abstract]   [Full Text] [Related]  

  • 34. Acne conglobata induced by adalimumab.
    Balakirski G; Neis MM; Megahed M
    Eur J Dermatol; 2017 Jun; 27(3):320-321. PubMed ID: 28524046
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute coronary syndrome in a Crohn's disease patient treated with adalimumab.
    Petitpain N; Bornert-Keller N; Peyrin-Biroulet L
    J Crohns Colitis; 2013 Oct; 7(9):e396. PubMed ID: 23523265
    [No Abstract]   [Full Text] [Related]  

  • 36. Certolizumab-induced guttate psoriasiform dermatitis.
    Fischer R; DaCunha M; Rajpara A
    Dermatol Online J; 2017 Jan; 23(1):. PubMed ID: 28329474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of adalimumab in a patient with Crohn's disease and extensive generalised psoriasis who achieved complete remission of both conditions].
    Piqueras M; Monfort D; Pol MA; Galter S; Modolell I; Ortiz J; Boadas J
    Gastroenterol Hepatol; 2013; 36(6):396-9. PubMed ID: 23587662
    [No Abstract]   [Full Text] [Related]  

  • 38. Adalimumab for the treatment of pediatric Crohn's disease.
    Nuti F; Fiorino G; Danese S
    Expert Rev Clin Immunol; 2015; 11(9):963-72. PubMed ID: 26211396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asymptomatic choroidal tubercle in a patient with Crohn's disease on adalimumab treatment.
    Asensio-Sánchez VM; Díaz-Cabanas L; Martín-Prieto A; Haro-Álvarez B
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Mar; 93(3):147-150. PubMed ID: 28743416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infliximab-induced palmoplantar pustulosis in a patient with crohn disease.
    Sladden MJ; Clarke PJ; Wettenhall J
    Arch Dermatol; 2007 Nov; 143(11):1449. PubMed ID: 18025378
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.